Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call Transcript October 30, 2024
Summit Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07.
Operator: Good morning. And welcome to Summit Therapeutics’ Q3 2024 Earnings and Update Call. All participants will be in a listen only mode until the question-and-answer portion of the call [Operator Instructions]. Please refer to the company’s Web site for updates. Please note that today’s...
